Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
12/2003
12/10/2003EP1368053A2 Compositions and methods for treating gonadotrophin related illnesses
12/10/2003EP1368037A2 Estrogen replacement therapy
12/10/2003EP1368036A1 Regulation of glucocorticoid concentration
12/10/2003EP1368025A2 Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor
12/10/2003EP1368007A1 Coating and binding agent for pharmaceutical formulations with improved storage stability
12/10/2003EP1368005A2 Chronotherapeutic dosage forms
12/10/2003EP1368001A2 Pharmaceutical formulation comprising bicalutamide
12/10/2003EP1368000A2 Chronotherapeutic dosage forms containing glucocorticosteroid
12/10/2003EP1367995A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues
12/10/2003EP1289985B1 Beta-carboline derivatives useful as inhibitors of phosphodiesterase
12/10/2003EP1115721B1 Pyrimidone derivatives
12/10/2003EP0666914B1 Novel p-selectin ligand protein
12/10/2003CN1461310A ANtibodies that bind human interleukin-18 and methods of making and using
12/10/2003CN1461308A Leucine-based motif and clostridial neurotoxins
12/10/2003CN1461211A Microparticles for pulmonary administation
12/10/2003CN1460487A Propolis soft capsule and its preparation method
12/10/2003CN1460482A Medicine composite containing icaritin and demethylicaritin and its application
12/10/2003CN1130459C Biological active molecules having potentiating effect on growth hormone biological activity
12/10/2003CN1130223C Pharmaceutical formulation containing growth hormone, amino acid and non-ionic detergent
12/09/2003US6660891 Methods for the production of D-chiro-inositol and the use of D-chiro inositol obtained therefrom
12/09/2003US6660752 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
12/09/2003US6660744 Pyrazolopyrimidines as therapeutic agents
12/09/2003US6660717 Folliculogenesis
12/09/2003CA2306103C Novel once-a-day controlled release sulfonylurea formulation
12/09/2003CA2227298C Paroxetine controlled release compositions
12/04/2003WO2003100435A2 Diagnostics and therapeutic use of neuromedin u receptor 2 (nmu2)
12/04/2003WO2003100434A2 Diagnostic and therapeutic use of the arginine vasopressin receptor 2 (avpr2)
12/04/2003WO2003100433A2 Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 3 (avpr3)
12/04/2003WO2003099864A1 Use of monocarboxylate transporter protein for thyroid hormone transport
12/04/2003WO2003099839A1 Modulators and inhibitors of fibroblast growth factor receptor 5_polypeptides and gene expression thereof.
12/04/2003WO2003099836A1 C-aryl glucoside sglt2 inhibitors and method
12/04/2003WO2003099820A1 Pyrazolo-pyrimidine aniline compounds
12/04/2003WO2003099814A1 Calcium receptor modulating agents
12/04/2003WO2003099811A1 Kinase inhibitors
12/04/2003WO2003099805A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003099773A1 Ccr9 inhibitors and methods of use thereof
12/04/2003WO2003099765A1 β-ALANINE DERIVATIVE AND USE THEREOF
12/04/2003WO2003099332A1 Medicinal composition for inhibiting the expression of atp-citrate lyase and use thereof
12/04/2003WO2003099292A1 Treatment of post-menopausal complaints in breast cancer patients comprising tibolone and a serm
12/04/2003WO2003099291A1 Progestagenic dosage units
12/04/2003WO2003099279A1 Combination of a dpp iv inhibitor and a cardiovascular compound
12/04/2003WO2003099201A2 Compositions and methods of use for a fibroblast growth factor
12/04/2003WO2003099192A2 Bis-aromatic alkanols
12/04/2003WO2003074485A3 Indole-amide derivatives and their use as glycogen phosphorylase inhibitors
12/04/2003WO2003063846A3 Aldosterone receptor antagonist and alpha-adrenergic modulating agent combination therapy for prevention or treatment of cardiovascular conditions
12/04/2003WO2003060096A3 Assay for the detection of factors that modulate the expression of ingap
12/04/2003WO2003051860A3 Substituted 2-phenyl benzofurans as estrogenic agents
12/04/2003WO2003046141A3 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
12/04/2003WO2003027085A3 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors
12/04/2003WO2003024946A3 Oxamate derivatives containing a variously substituted nitrogen heterocycle
12/04/2003WO2003015748A3 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
12/04/2003WO2002057427A3 Mammalian tumor susceptibility gene products and their uses
12/04/2003US20030225280 2-Amino-N-(1(R)-benzvloxymethyl-2-(1,3-dioxo-8a(S)-pyridin-2-y lmethyl-2-(2,2,2-trifluoro-ethyl)-hexahydroimidazo(1,5-a)pyraz in-7-yl)-2-oxo- ethyl)-2-methyl-propionamide chloride from piperazine-2-carboxylate esters
12/04/2003US20030225273 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
12/04/2003US20030225151 Pyrazole compositions useful as inhibitors of ERK
12/04/2003US20030225132 Heterocyclic salts such as 3-(3-Hydroxyphenyl)-2-(4-(2-(1-pyrrolidinium)ethoxyphenol)-2,3-dihydro-1,4 -benzoxathiin-6-ol hydrochloride salt, used as estrane agonists, for phrophylaxis of bone disorders
12/04/2003US20030225130 Triphenylalkene derivatives and their use as selective estrogen receptor modulators
12/04/2003US20030225113 E.g., tert-Butyl-5-amino-2-methylthio-4-(3-methoxyphenyl)-quinazoline-6 -carboxamide; used in fertility regulation therapies.
12/04/2003US20030225109 Inducing contraception, treat progesterone-related carcinomas and adenocarcinomas; hormone replacement therapy
12/04/2003US20030225102 Dipeptidyl peptidase inhibitors; heterocyclic amide and semicarbazide derivatives, e.g., (2-Cyano-1-(piperazine-2-yl)-carbonyl pyrrolidine bis-trifluoroacetate
12/04/2003US20030225095 Method of affecting sleep and sleep-related behaviors
12/04/2003US20030225051 Also estrogen phosphonates, thiophosphonates, sulphonates, sulphonamides, and N-acylsulfamates
12/04/2003US20030225050 Process for production of crystals of 11ss-benzaldoxim-estra-4,9-diene derivatives, crystals obtained thereby and pharmaceutical preparations containing them
12/04/2003US20030225047 Sulfatase inhibiting progestogen-only contraceptive regimens
12/04/2003US20030223969 Method of modulating inflammatory response
12/04/2003CA2784937A1 Ccr9 inhibitors and methods of use thereof
12/04/2003CA2487557A1 Modulators and inhibitors of fibroblast growth factor receptor 5 polypeptides and gene expression thereof
12/04/2003CA2487279A1 Progestagenic dosage units
12/04/2003CA2487268A1 Treatment of post-menopausal complaints in breast cancer patients comprising tibolone and a serm
12/04/2003CA2487167A1 Combination of a dpp iv inhibitor and a cardiovascular compound
12/04/2003CA2486853A1 Bis-aromatic alkanols
12/04/2003CA2486187A1 Kinase inhibitors
12/04/2003CA2484822A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
12/04/2003CA2484274A1 Compositions and methods of use for a fibroblast growth factor
12/03/2003EP1366162A2 Putative proteins and nucleic acids encoding same
12/03/2003EP1366161A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof
12/03/2003EP1366079A2 Nuclear hormone receptor ligand binding domain
12/03/2003EP1366078A2 Ige receptor antagonists
12/03/2003EP1366012A2 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
12/03/2003EP1365809A2 Methods for reducing chronic stress in mammals
12/03/2003EP1365800A2 Methods for using tetanus toxin for benificial purposes in animals (mammals)
12/03/2003EP1365798A2 Use of serp-1 in combination with an immunosuppressant for influencing inflammatory and immune reactions
12/03/2003EP1365760A1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester
12/03/2003EP1365745A2 Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
12/03/2003EP1257555B1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
12/03/2003EP1246634B1 Neurotoxins for treating pancreatic disorders
12/03/2003EP0854715B1 Methods of inhibiting plasminogen activator inhibitor 1
12/03/2003CN1460018A Implantable gel compositions and method of mfg.
12/03/2003CN1129606C Heptapeptide oxytocin analogues
12/03/2003CN1129602C 11-(substituted phenyl) estra-4,9-diene derivatives
12/03/2003CN1129433C Use of formyl amine for preparing composition for treating lipsotrichia
12/02/2003US6656939 Pyrazole compounds useful as protein kinase inhibitors
11/2003
11/27/2003WO2003097862A1 Method of searching substane having antidiabetic activity
11/27/2003WO2003097083A1 Medicinal compositions containing ghrelin
11/27/2003WO2003097082A2 Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies
11/27/2003WO2003097071A1 Hormone replacement therapy using a combination of conjugated estrogens and trimegestone
11/27/2003WO2003097067A1 Combination of an ace inhibitor, a calcium channel blocker and a diuretic
11/27/2003WO2003097047A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
11/27/2003WO2003097045A1 Combination of organic compounds
1 ... 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 ... 290